Loring Wolcott & Coolidge Fiduciary Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.8K | Hold |
|
|||||
|
2025
Q2 | $11.6K | Hold |
|
|||||
|
2025
Q1 | $9.12K | Hold |
|
|||||
|
2024
Q4 | $6.29K | Hold |
|
|||||
|
2024
Q3 | $8.84K | Hold |
|
|||||
|
2024
Q2 | $4.25K | Hold |
|
|||||
|
2024
Q1 | $3.57K | Hold |
|
|||||
|
2023
Q4 | $28.8K | Hold |
|
|||||
|
2023
Q3 | $32.5K | Hold |
|
|||||
|
2023
Q2 | $38.9K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $51K | Buy |
|